Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease

Citations Over TimeTop 1% of 2015 papers

Abstract

Tissue fibrosis is a core pathologic process that contributes to mortality in ~45% of the population and is likely to be influenced by the host genetic architecture. Here we demonstrate, using liver disease as a model, that a single-nucleotide polymorphism (rs12979860) in the intronic region of interferon-λ4 (IFNL4) is a strong predictor of fibrosis in an aetiology-independent manner. In a cohort of 4,172 patients, including 3,129 with chronic hepatitis C (CHC), 555 with chronic hepatitis B (CHB) and 488 with non-alcoholic fatty liver disease (NAFLD), those with rs12979860CC have greater hepatic inflammation and fibrosis. In CHC, those with rs12979860CC also have greater stage-constant and stage-specific fibrosis progression rates (P<0.0001 for all). The impact of rs12979860 genotypes on fibrosis is maximal in young females, especially those with HCV genotype 3. These findings establish rs12979860 genotype as a strong aetiology-independent predictor of tissue inflammation and fibrosis.

Related Papers

• → A comprehensive in Silico analysis of the functional and structural impact of single nucleotide polymorphisms (SNPs) in the human IL-33 gene(2021)9 cited
• → Identification of SNPs Affecting Porcine Carcass Weight with the 60K SNP Chip(2013)4 cited
• → Association of Single Nucleotide Polymorphisms with Periodontitis in the Japanese Population.(2002)1 cited
• → SNPs in the SCGB3A2 promoter are associated with susceptibility to Graves’ disease(2012)
• Association between the position-654G/A and-1429T/A single nucleotide polymorphisms(SNP) existing in 5′-regulatory region of β_2-adrenoceptor(β_2-AR) gene and risk of essential hypertension in Uighur of Xinjiang(2010)